Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer
Status:
Not yet recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
This registry aims to evaluate the efficacy of using high-dose oral progestin in young women
with stage I endometrial adenocarcinoma with grade 2 differentiation or superficial
myometrial invasion as a fertility-sparing management.